Also known as ea pharma
EA Pharma Co., Ltd. is a gastrointestinal specialty pharmaceutical company with a full value chain spanning research and development, production logistics, and sales and marketing. It was created from the digestive business of the Eisai Group, which has operated for more than 60 years, together with the amino acid based digestive business of the Ajinomoto Group. This description comes from the company's own website.
Browse more corporate investors and other institutional investors by location and type in the LPbacked limited-partner database.
EA Pharma is a corporate investor based in Tokyo, Japan, managing approximately $683M in assets.
EA Pharma is headquartered in Tokyo, Japan.
EA Pharma manages approximately $683M in assets under management.
EA Pharma was founded in 2016.
EA Pharma focuses on Early Stage, Biotechnology, Healthcare, Medical Devices & Equipment, Pharmaceuticals.
Verified contact details, key decision-makers, and investment preferences for EA Pharma are available on LPbacked. Create a free account to access them.